Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017

被引：15
|
作者：
Frank I. Scott
Gary R. Lichtenstein
机构：
[1] University of Colorado Anschutz Medical Campus,Crohn’s and Colitis Center, Division of Gastroenterology and Hepatology
[2] Perelman School of Medicine,Gastroenterology Division
[3] University of Pennsylvania,undefined
来源：
Current Treatment Options in Gastroenterology | 2018年 / 16卷 / 1期
关键词：
Biosimilars; Indication extrapolation; Interchangeability; Infliximab; Adalimumab; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis;
D O I：
10.1007/s11938-018-0177-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 164
页数：17
相关论文
共 50 条
  • [1] Insights on the use of biosimilars in the treatment of inflammatory bowel disease
    Zheng, Michael K.
    Shih, David Q.
    Chen, Gary C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (11) : 1932 - 1943
  • [2] Insights on the use of biosimilars in the treatment of inflammatory bowel disease
    Michael K Zheng
    David Q Shih
    Gary C Chen
    World Journal of Gastroenterology, 2017, (11) : 1932 - 1943
  • [3] Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence
    McConachie, Sean
    Wilhelm, Sheila M.
    Kale-Pradhan, Pramodini B.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (04) : 391 - 400
  • [4] Biosimilars in paediatric inflammatory bowel disease
    Sieczkowska-Golub, Joanna
    Jarzebicka, Dorota
    Oracz, Grzegorz
    Kierkus, Jaroslaw
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (35) : 4021 - 4027
  • [5] Biosimilars in paediatric inflammatory bowel disease
    Joanna Sieczkowska-Golub
    Dorota Jarzebicka
    Grzegorz Oracz
    Jaroslaw Kierkus
    World Journal of Gastroenterology, 2018, (35) : 4021 - 4027
  • [6] Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
    Argollo, Marjorie
    Fiorino, Gionata
    Gilardi, Daniela
    Furfaro, Federica
    Roda, Giulia
    Loy, Laura
    Allocca, Mariangela
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (01) : 7 - 12
  • [7] Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease
    Macaluso, Fabio Salvatore
    Leone, Salvatore
    Previtali, Enrica
    Ventimiglia, Marco
    Armuzzi, Alessandro
    Orlando, Ambrogio
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (11) : 1304 - 1309
  • [8] Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
    Fiorino, Gionata
    Caprioli, Flavio
    Daperno, Marco
    Mocciaro, Filippo
    Principi, Mariabeatrice
    Viscido, Angelo
    Fantini, Massimo Claudio
    Orlando, Ambrogio
    Papi, Claudio
    Annese, Vito
    Danese, Silvio
    Vecchi, Maurizio
    Rizzello, Fernando
    Armuzzi, Alessandro
    Leone, Salvatore
    Previtali, Enrica
    Aloi, Marina
    Alvisi, Patrizia
    Antonelli, Elisabetta
    Ardizzone, Sandro
    Astegiano, Marco
    Baldoni, Monia
    Beltrami, Marina
    Biancone, Livia
    Bodini, Giorgia
    Buda, Andrea
    Bossa, Fabrizio
    Bracci, Fiammetta
    Calabrese, Emma
    Cappello, Maria
    Castiglione, Fabiana
    Ciacci, Carolina
    Cicala, Michele
    Ciccocioppo, Rachele
    Comberlato, Michele
    Cortelezzi, Claudio Camillo
    Cosintino, Rocco
    Costa, Francesco
    Costantino, Giuseppe
    Cucchiara, Salvatore
    Cuomo, Antonio
    D'Inca, Renata
    Di Paolo, Maria Carla
    Di Sabatino, Antonio
    Di Sario, Antonio
    Frieri, Giuseppe
    Fries, Walter
    Gasbarrini, Antonio
    Geccherle, Andrea
    Gionchetti, Paolo
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (05) : 632 - 639
  • [9] Biosimilars in inflammatory bowel disease
    Gargallo, Carla J.
    Lue, Alberto
    Gomollon, Fernando
    MINERVA MEDICA, 2017, 108 (03) : 239 - 254
  • [10] Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
    Rawla, Prashanth
    Sunkara, Tagore
    Raj, Jeffrey Pradeep
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 215 - 226
12345